The attenuated ANXA1 levels observed in lipodystrophy patients with low adiposity and in obese participants with high adiposity may therefore result from an increased systemic inflammatory environment where the balance of inflammation is tipped in favour of pro-inflammatory factors (Figure 5). This evidence concerns the gene ANXA1 and lipodystrophy.